In the News

201 News Items found
MSK's Mark Awad, MD, PhD, is seen smiling.
Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.
(From left) David Scheinberg, Andrew Zelenetz, and Joseph Jurcic are using monoclonal antibodies to improve the treatment of patients with leukemia and lymphoma.
Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.
MSK's Wungki Park, MD, seen smiling in laboratory.
Learn how a novel drug is showing promise against lung and pancreatic cancer in early clinical trials by targeting the KRAS G12D mutation with a KRAS degrader.
Amy Speck
Feature
MSK surgeons have regularly used robotic surgery since 2007 to remove certain tumors in the chest and abdominal cavity. Now they are using robotic surgery to remove noncancerous tumors of the spine.
Zsofia Stadler presents at the ASCO meeting
Finding
Tumors with a biomarker called high microsatellite instability have been linked to inherited cancer mutations.
Learn how exercise can help many people live longer after they are diagnosed with cancer, according to a new study from MSK's Exercise-Oncology Service.
doctor and patients
In the Clinic
Discover how a watch-and-wait approach to treating rectal cancer can help people avoid surgery and preserve normal body functions.
Dr. Karuna Ganesh and Elizabeth Benitez in the lab.
Metastasis is responsible for about 9 of every 10 cancer deaths, and it remains one of the most daunting and least understood aspects of the disease. Researchers across MSK are approaching a wide variety of metastatic cancer types from many directions.
Dr. Prasad Adusumilli sits at a computer. A patient’s face and a chest image are on the screen.
Feature
Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion.
Kelly Spill is seen outdoors holding her newborn and talking with Dr. Andrea Cercek of Memorial Sloan Kettering Cancer Center.
Learn how a heralded clinical trial that made rectal cancer disappear for every participant is being expanded at Memorial Sloan Kettering Cancer Center. The trial uses only immunotherapy that targets a rare mutation — without the need for surgery, chemotherapy, or radiation.